GB833458A - Drug composition - Google Patents
Drug compositionInfo
- Publication number
- GB833458A GB833458A GB27387/56A GB2738756A GB833458A GB 833458 A GB833458 A GB 833458A GB 27387/56 A GB27387/56 A GB 27387/56A GB 2738756 A GB2738756 A GB 2738756A GB 833458 A GB833458 A GB 833458A
- Authority
- GB
- United Kingdom
- Prior art keywords
- copolymers
- drug
- methacrylate
- monovinylidene
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940079593 drug Drugs 0.000 title abstract 13
- 239000003814 drug Substances 0.000 title abstract 13
- 239000000203 mixture Substances 0.000 title abstract 4
- 229920001577 copolymer Polymers 0.000 abstract 11
- -1 aralkyl acrylates Chemical class 0.000 abstract 9
- 150000001875 compounds Chemical class 0.000 abstract 9
- 229920000642 polymer Polymers 0.000 abstract 6
- 239000007787 solid Substances 0.000 abstract 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 4
- 239000002245 particle Substances 0.000 abstract 4
- 229920005989 resin Polymers 0.000 abstract 4
- 239000011347 resin Substances 0.000 abstract 4
- 239000011159 matrix material Substances 0.000 abstract 3
- 229920002554 vinyl polymer Polymers 0.000 abstract 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N 1-ethenoxybutane Chemical compound CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 abstract 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 abstract 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 abstract 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 2
- 239000005977 Ethylene Substances 0.000 abstract 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 abstract 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 abstract 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 abstract 2
- 150000001241 acetals Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 238000009792 diffusion process Methods 0.000 abstract 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 abstract 2
- 238000002386 leaching Methods 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 abstract 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 abstract 2
- 229960001252 methamphetamine Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 abstract 2
- 229920003023 plastic Polymers 0.000 abstract 2
- 239000004033 plastic Substances 0.000 abstract 2
- 229920000573 polyethylene Polymers 0.000 abstract 2
- 229920003002 synthetic resin Polymers 0.000 abstract 2
- 239000000057 synthetic resin Substances 0.000 abstract 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 abstract 1
- BMFDVOCTLCOHPA-UHFFFAOYSA-N 1-cyclohexyloxyethanol Chemical compound CC(O)OC1CCCCC1 BMFDVOCTLCOHPA-UHFFFAOYSA-N 0.000 abstract 1
- HWCLMKDWXUGDKL-UHFFFAOYSA-N 1-ethenoxy-2-ethoxyethane Chemical compound CCOCCOC=C HWCLMKDWXUGDKL-UHFFFAOYSA-N 0.000 abstract 1
- RECMXJOGNNTEBG-UHFFFAOYSA-N 1-phenylmethoxyethanol Chemical compound CC(O)OCC1=CC=CC=C1 RECMXJOGNNTEBG-UHFFFAOYSA-N 0.000 abstract 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 abstract 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 abstract 1
- DJIHQRBJGCGSIR-UHFFFAOYSA-N 2-methylidene-1,3-dioxepane-4,7-dione Chemical compound C1(CCC(=O)OC(=C)O1)=O DJIHQRBJGCGSIR-UHFFFAOYSA-N 0.000 abstract 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 abstract 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 abstract 1
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 abstract 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 abstract 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 abstract 1
- 241001106067 Atropa Species 0.000 abstract 1
- 229930003347 Atropine Natural products 0.000 abstract 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 abstract 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 239000004698 Polyethylene Substances 0.000 abstract 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 abstract 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 abstract 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 abstract 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 abstract 1
- 125000005250 alkyl acrylate group Chemical group 0.000 abstract 1
- 229960004050 aminobenzoic acid Drugs 0.000 abstract 1
- 229940025084 amphetamine Drugs 0.000 abstract 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 abstract 1
- 229960000396 atropine Drugs 0.000 abstract 1
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 238000012662 bulk polymerization Methods 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 229920003086 cellulose ether Polymers 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000004132 cross linking Methods 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- ZEFVHSWKYCYFFL-UHFFFAOYSA-N diethyl 2-methylidenebutanedioate Chemical compound CCOC(=O)CC(=C)C(=O)OCC ZEFVHSWKYCYFFL-UHFFFAOYSA-N 0.000 abstract 1
- ZWWQRMFIZFPUAA-UHFFFAOYSA-N dimethyl 2-methylidenebutanedioate Chemical compound COC(=O)CC(=C)C(=O)OC ZWWQRMFIZFPUAA-UHFFFAOYSA-N 0.000 abstract 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000007720 emulsion polymerization reaction Methods 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 abstract 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 238000010528 free radical solution polymerization reaction Methods 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000003163 gonadal steroid hormone Substances 0.000 abstract 1
- ZNAOFAIBVOMLPV-UHFFFAOYSA-N hexadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)=C ZNAOFAIBVOMLPV-UHFFFAOYSA-N 0.000 abstract 1
- LNCPIMCVTKXXOY-UHFFFAOYSA-N hexyl 2-methylprop-2-enoate Chemical compound CCCCCCOC(=O)C(C)=C LNCPIMCVTKXXOY-UHFFFAOYSA-N 0.000 abstract 1
- 229920001519 homopolymer Polymers 0.000 abstract 1
- 150000001469 hydantoins Chemical class 0.000 abstract 1
- 150000003951 lactams Chemical class 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- DGMJZELBSFOPHH-KVTDHHQDSA-N mannite hexanitrate Chemical compound [O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)CO[N+]([O-])=O DGMJZELBSFOPHH-KVTDHHQDSA-N 0.000 abstract 1
- 229960001765 mannitol hexanitrate Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 150000002763 monocarboxylic acids Chemical class 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- ZIWDVJPPVMGJGR-UHFFFAOYSA-N n-ethyl-2-methylprop-2-enamide Chemical compound CCNC(=O)C(C)=C ZIWDVJPPVMGJGR-UHFFFAOYSA-N 0.000 abstract 1
- YPHQUSNPXDGUHL-UHFFFAOYSA-N n-methylprop-2-enamide Chemical compound CNC(=O)C=C YPHQUSNPXDGUHL-UHFFFAOYSA-N 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 229960001412 pentobarbital Drugs 0.000 abstract 1
- 229960005323 phenoxyethanol Drugs 0.000 abstract 1
- 229920002587 poly(1,3-butadiene) polymer Polymers 0.000 abstract 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 abstract 1
- 238000006116 polymerization reaction Methods 0.000 abstract 1
- 239000004800 polyvinyl chloride Substances 0.000 abstract 1
- 229920000915 polyvinyl chloride Polymers 0.000 abstract 1
- 229920001290 polyvinyl ester Polymers 0.000 abstract 1
- 229920000131 polyvinylidene Polymers 0.000 abstract 1
- 239000005033 polyvinylidene chloride Substances 0.000 abstract 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 abstract 1
- 238000005245 sintering Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 238000010557 suspension polymerization reaction Methods 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 abstract 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
- 229920001169 thermoplastic Polymers 0.000 abstract 1
- JIVZKJJQOZQXQB-UHFFFAOYSA-N tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002312 tolazoline Drugs 0.000 abstract 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 abstract 1
- 229960004453 trimethadione Drugs 0.000 abstract 1
- IRYJRGCIQBGHIV-UHFFFAOYSA-N trimethadione Chemical compound CN1C(=O)OC(C)(C)C1=O IRYJRGCIQBGHIV-UHFFFAOYSA-N 0.000 abstract 1
- 229940117958 vinyl acetate Drugs 0.000 abstract 1
- 235000019156 vitamin B Nutrition 0.000 abstract 1
- 239000011720 vitamin B Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229910001868 water Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US833458XA | 1955-09-09 | 1955-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB833458A true GB833458A (en) | 1960-04-27 |
Family
ID=22177729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB27387/56A Expired GB833458A (en) | 1955-09-09 | 1956-09-06 | Drug composition |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE575343A (enrdf_load_stackoverflow) |
| DE (1) | DE1123437B (enrdf_load_stackoverflow) |
| FR (1) | FR1207404A (enrdf_load_stackoverflow) |
| GB (1) | GB833458A (enrdf_load_stackoverflow) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3091574A (en) * | 1961-09-05 | 1963-05-28 | Bristol Myers Co | Tablet disintegrants |
| DE1174452B (de) * | 1962-01-13 | 1964-07-23 | Knoll Ag | Verfahren zur Herstellung gastrointestinal resorbierbarer Arzneimittelzubereitungen |
| DE1279896B (de) * | 1960-06-06 | 1968-10-10 | American Home Prod | Die Verwendung eines sauren Copolymerisates zur Herstellung von Tabletten mit verlaengerter Wirkstoffabgabe |
| FR2157847A1 (enrdf_load_stackoverflow) * | 1971-10-12 | 1973-06-08 | Lilly Co Eli | |
| GB2257358A (en) * | 1991-06-12 | 1993-01-13 | Wheli Inter Ag | Protected vital substances |
| EP1175899A1 (fr) * | 2000-07-27 | 2002-01-30 | Roquette FrÀ¨res | Granules à base d'amidon et de lactose |
| FR2826549A1 (fr) * | 2001-06-28 | 2003-01-03 | Roquette Freres | Procede de preparation d'un comprime edulcorant et comprime edulcorant ainsi obtenu. |
| WO2003102072A1 (en) * | 2002-05-30 | 2003-12-11 | Granate Seed Limited | Starch products involving a starch-lipid complex, their preparation and uses |
| JP2005529068A (ja) * | 2002-01-21 | 2005-09-29 | レ ラボラトワール セルヴィエ | ピリベジルの口内分散性薬剤組成物 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE636865A (enrdf_load_stackoverflow) * | 1962-08-31 | |||
| DE1258025B (de) * | 1963-05-11 | 1968-01-04 | Diwag Chemische Fabriken G M B | Verfahren zur Herstellung von oral anzuwendenden Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe |
| DE3314003A1 (de) * | 1983-04-18 | 1984-10-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung |
| DE4118550C2 (de) * | 1991-06-06 | 1996-09-26 | Rademacher Karl Heinz Dr Rer N | Tierarzneimittel |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE631201C (de) * | 1932-08-07 | 1936-06-16 | Chemische Forschungs Gmbh | Traegerstoff fuer Arzneimittel |
| CH283585A (de) * | 1950-03-15 | 1952-06-15 | Hoffmann La Roche | Zur Herstellung von Tablettenüberzügen geeignetes Gemisch. |
-
0
- BE BE575343D patent/BE575343A/xx unknown
-
1956
- 1956-09-05 FR FR1207404D patent/FR1207404A/fr not_active Expired
- 1956-09-06 GB GB27387/56A patent/GB833458A/en not_active Expired
- 1956-09-08 DE DER19604A patent/DE1123437B/de active Pending
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1279896B (de) * | 1960-06-06 | 1968-10-10 | American Home Prod | Die Verwendung eines sauren Copolymerisates zur Herstellung von Tabletten mit verlaengerter Wirkstoffabgabe |
| DE1279896C2 (de) * | 1960-06-06 | 1974-03-14 | American Home Prod | Die Verwendung eines sauren Copolymerisates zur Herstellung von Tabletten mit verlaengerter Wirkstoffabgabe |
| US3091574A (en) * | 1961-09-05 | 1963-05-28 | Bristol Myers Co | Tablet disintegrants |
| DE1174452B (de) * | 1962-01-13 | 1964-07-23 | Knoll Ag | Verfahren zur Herstellung gastrointestinal resorbierbarer Arzneimittelzubereitungen |
| FR2157847A1 (enrdf_load_stackoverflow) * | 1971-10-12 | 1973-06-08 | Lilly Co Eli | |
| GB2257358A (en) * | 1991-06-12 | 1993-01-13 | Wheli Inter Ag | Protected vital substances |
| GB2257358B (en) * | 1991-06-12 | 1996-01-03 | Wheli Inter Ag | Protected vital substances |
| WO2002009673A1 (fr) * | 2000-07-27 | 2002-02-07 | Roquette Freres | Granules a base d'amidon et de lactose |
| EP1175899A1 (fr) * | 2000-07-27 | 2002-01-30 | Roquette FrÀ¨res | Granules à base d'amidon et de lactose |
| JP2002142690A (ja) * | 2000-07-27 | 2002-05-21 | Roquette Freres | デンプン及びラクトースに基づく顆粒 |
| US6770368B2 (en) | 2000-07-27 | 2004-08-03 | Roquette Freres | Granules based on starch and lactose |
| AU785135B2 (en) * | 2000-07-27 | 2006-10-05 | Roquette Freres | Granules based on starch and lactose |
| CZ303682B6 (cs) * | 2000-07-27 | 2013-03-06 | Roquette Freres | Granule na bázi laktózy a skrobu a zpusob jejich výroby |
| FR2826549A1 (fr) * | 2001-06-28 | 2003-01-03 | Roquette Freres | Procede de preparation d'un comprime edulcorant et comprime edulcorant ainsi obtenu. |
| WO2003001925A3 (fr) * | 2001-06-28 | 2003-04-17 | Roquette Freres | Procede de preparation d'un comprime edulcorant et comprime edulcorant ainsi obtenu |
| JP2005529068A (ja) * | 2002-01-21 | 2005-09-29 | レ ラボラトワール セルヴィエ | ピリベジルの口内分散性薬剤組成物 |
| WO2003102072A1 (en) * | 2002-05-30 | 2003-12-11 | Granate Seed Limited | Starch products involving a starch-lipid complex, their preparation and uses |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1123437B (de) | 1962-02-08 |
| BE575343A (enrdf_load_stackoverflow) | |
| FR1207404A (fr) | 1960-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB833458A (en) | Drug composition | |
| US6576255B1 (en) | Injection molding method for (meth)acrylate copolymers having tertiary ammonium groups | |
| US4801460A (en) | Preparation of solid pharmaceutical forms | |
| Follonier et al. | Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained release capsules containing high loadings of freely soluble drugs | |
| US3775537A (en) | Copolymer coatings for pharmaceuticals | |
| GB1116670A (en) | Process for the manufacture of pharmaceutical preparations in bead form | |
| US20080260814A1 (en) | Injection moulding process for neutral and acid-group-containing (meth)acrylate copolymers | |
| US6878387B1 (en) | Coated medicament forms with controlled active substance release | |
| GB1135966A (en) | Improvements in or relating to sustained-release medicaments | |
| KR20000036066A (ko) | 압출성형에 의한 고상 제형의 제조 방법 | |
| JP4813634B2 (ja) | 固形投与形の製造法、該投与形及び結合剤としてのグラフトコポリマーの使用 | |
| JPH02107261A (ja) | 医薬錠剤の製造方法 | |
| WO2004100883A2 (en) | Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutual dosage forms and methods of preparing the same | |
| IE46594B1 (en) | Copolymers of methyl methacrylate and nitrogen-containing acrylate or methacrylate esters | |
| US3073748A (en) | Coated medicaments | |
| GB1039067A (en) | Process for preparing derivatives of polyvinyl alcohol | |
| GB1350255A (en) | Tablets having a sustained release of active substance | |
| JPS6477682A (en) | Composition for carpet backing | |
| JPS5854957A (ja) | 医療器材用成形物の製造方法 | |
| GB1278816A (en) | Improvements in or relating to controlled release pharmaceutical compositions | |
| KR100469943B1 (ko) | 장용성 코팅제로 사용되는 아크릴 공중합체의 제조 방법 | |
| GB1382726A (en) | Methods of preventing build-up in a polymerization reactor | |
| GB1065577A (en) | Cross-linked polymers and process for preparing them | |
| Cameron | Physicochemical properties of controlled-release theophylline tablets containing acrylic resins | |
| GB1087195A (en) | Process for the polymerisation of vinyl chloride |